$KSCP
Knightscope, Inc.

2022 Q1 Form 10-Q Financial Statement

#000141057822001693 Filed on May 16, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $944.0K $866.0K
YoY Change 9.01%
Cost Of Revenue $1.493M $1.183M
YoY Change 26.2%
Gross Profit -$549.0K -$317.0K
YoY Change 73.19%
Gross Profit Margin -58.16% -36.61%
Selling, General & Admin $5.816M $3.613M
YoY Change 60.97%
% of Gross Profit
Research & Development $1.838M $1.127M
YoY Change 63.09%
% of Gross Profit
Depreciation & Amortization $351.0K $328.0K
YoY Change 7.01%
% of Gross Profit
Operating Expenses $7.654M $4.740M
YoY Change 61.48%
Operating Profit -$8.203M -$5.057M
YoY Change 62.21%
Interest Expense -$8.911M -$540.0K
YoY Change 1550.19%
% of Operating Profit
Other Income/Expense, Net -$1.394M -$520.0K
YoY Change 168.08%
Pretax Income -$9.597M -$5.577M
YoY Change 72.08%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$9.597M -$5.577M
YoY Change 72.08%
Net Earnings / Revenue -1016.63% -644.0%
Basic Earnings Per Share -$0.30 -$0.56
Diluted Earnings Per Share -$0.30 -$0.56
COMMON SHARES
Basic Shares Outstanding 31.70M 10.19M
Diluted Shares Outstanding 31.70M 10.19M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $21.10M
YoY Change
Cash & Equivalents $21.10M $7.435M
Short-Term Investments
Other Short-Term Assets $1.257M
YoY Change
Inventory
Prepaid Expenses
Receivables $1.972M
Other Receivables $0.00
Total Short-Term Assets $24.32M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $148.0K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $78.00K
YoY Change
Total Long-Term Assets $4.545M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $24.32M
Total Long-Term Assets $4.545M
Total Assets $28.87M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.080M
YoY Change
Accrued Expenses $450.0K
YoY Change
Deferred Revenue $1.299M
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $4.591M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $22.98M
YoY Change
Total Long-Term Liabilities $22.98M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.591M
Total Long-Term Liabilities $22.98M
Total Liabilities $27.57M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$123.3M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$38.67M -$71.71M
YoY Change
Total Liabilities & Shareholders Equity $28.87M
YoY Change

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$9.597M -$5.577M
YoY Change 72.08%
Depreciation, Depletion And Amortization $351.0K $328.0K
YoY Change 7.01%
Cash From Operating Activities -$8.352M -$5.758M
YoY Change 45.05%
INVESTING ACTIVITIES
Capital Expenditures $41.00K $10.00K
YoY Change 310.0%
Acquisitions
YoY Change
Other Investing Activities -$760.0K -$380.0K
YoY Change 100.0%
Cash From Investing Activities -$805.0K -$387.0K
YoY Change 108.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 19.50M 6.423M
YoY Change 203.64%
NET CHANGE
Cash From Operating Activities -8.352M -5.758M
Cash From Investing Activities -805.0K -387.0K
Cash From Financing Activities 19.50M 6.423M
Net Change In Cash 10.35M 278.0K
YoY Change 3621.58%
FREE CASH FLOW
Cash From Operating Activities -$8.352M -$5.758M
Capital Expenditures $41.00K $10.00K
Free Cash Flow -$8.393M -$5.768M
YoY Change 45.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
50000
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31702815
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10189000
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
13586502
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
19617107
CY2021Q1 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2022Q1 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2022Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q1 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2022Q1 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2021Q1 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2022Q1 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001600983
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-41248
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
Knightscope, Inc.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2482575
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1070 Terra Bella Avenue
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Mountain View
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94043
CY2022Q1 dei City Area Code
CityAreaCode
650
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
924-1025
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.001 per share
CY2022Q1 dei Trading Symbol
TradingSymbol
KSCP
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25850946
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21095000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10749000
CY2022Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
100000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
100000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
250000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
250000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1972000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1189000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1157000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1299000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
24324000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
13337000
CY2022Q1 kscp Autonomous Security Robots Net
AutonomousSecurityRobotsNet
3389000
CY2021Q4 kscp Autonomous Security Robots Net
AutonomousSecurityRobotsNet
2971000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
148000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
117000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
930000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1077000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
78000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
78000
CY2022Q1 us-gaap Assets
Assets
28869000
CY2021Q4 us-gaap Assets
Assets
17580000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1080000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1514000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
450000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1191000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1299000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
889000
CY2021Q4 us-gaap Debt Current
DebtCurrent
7109000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
672000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
648000
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1090000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
893000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4591000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10189000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
866000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1493000
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1183000
CY2022Q1 us-gaap Gross Profit
GrossProfit
-549000
CY2021Q1 us-gaap Gross Profit
GrossProfit
-317000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12244000
CY2022Q1 kscp Preferred Stock Warrant Liability Noncurrent
PreferredStockWarrantLiabilityNoncurrent
22674000
CY2021Q4 kscp Preferred Stock Warrant Liability Noncurrent
PreferredStockWarrantLiabilityNoncurrent
30566000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
307000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
485000
CY2022Q1 us-gaap Liabilities
Liabilities
27572000
CY2021Q4 us-gaap Liabilities
Liabilities
43295000
CY2022Q1 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
43405324
CY2021Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
43405324
CY2022Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
13586502
CY2021Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
19617107
CY2022Q1 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
42546000
CY2022Q1 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
39971000
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
57218000
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
84586000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30745000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-123294000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-113697000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-38674000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-82933000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28869000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17580000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
944000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1838000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1127000
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3490000
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3069000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2326000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
544000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
7654000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
4740000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8203000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5057000
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-8911000
CY2021Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-540000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7522000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1394000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-520000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9597000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5577000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-9597000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5577000
CY2021Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
175000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9597000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5752000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31702815
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1325000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
253000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-142000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-66185000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
231000
CY2021Q1 kscp Temporary Equity Of Accrued Dividends
TemporaryEquityOfAccruedDividends
175000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5577000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-71706000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-82933000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
725000
CY2022Q1 kscp Adjustments To Additional Paid In Capital Warrant Expired
AdjustmentsToAdditionalPaidInCapitalWarrantExpired
370000
CY2022Q1 kscp Stock Issued During Period Value Conversion Of Convertible Notes
StockIssuedDuringPeriodValueConversionOfConvertibleNotes
16011000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
97000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
19456000
CY2022Q1 kscp Temporary Equity Share Conversion To Common Stock
TemporaryEquityShareConversionToCommonStock
-17247000
CY2022Q1 kscp Adjustments To Additional Paid In Capital Share Conversion Costs
AdjustmentsToAdditionalPaidInCapitalShareConversionCosts
-50000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-9597000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-38674000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-9597000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-5577000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
351000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
328000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
725000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
231000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7522000
CY2022Q1 us-gaap Financing Receivable Accrued Interest Writeoff
FinancingReceivableAccruedInterestWriteoff
24000
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
8878000
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
384000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
783000
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-142000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-434000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
582000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-741000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-140000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
410000
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-365000
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
195000
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
235000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8352000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5758000
CY2022Q1 kscp Purchases And Related Costs Incurred For Autonomous Security Robots
PurchasesAndRelatedCostsIncurredForAutonomousSecurityRobots
764000
CY2021Q1 kscp Purchases And Related Costs Incurred For Autonomous Security Robots
PurchasesAndRelatedCostsIncurredForAutonomousSecurityRobots
377000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
41000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-805000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-387000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
97000
CY2021Q1 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
6423000
CY2022Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
19456000
CY2022Q1 kscp Autonomous Security Robots Accumulated Depreciation On Finished Product
AutonomousSecurityRobotsAccumulatedDepreciationOnFinishedProduct
6832000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19503000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6423000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10346000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
278000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10849000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7157000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21195000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7435000
CY2022Q1 kscp Conversion Of Preferred Stock To Common Stock
ConversionOfPreferredStockToCommonStock
17247000
CY2022Q1 kscp Conversion Of Debt Obligations To Common Stock
ConversionOfDebtObligationsToCommonStock
16011000
CY2021Q1 kscp Series M4 Accrued Dividend
SeriesM4AccruedDividend
175000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21100000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10700000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-123300000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-38700000
CY2022Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2236619
CY2022Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
19500000
CY2022Q2 kscp Value Of Common Stock Issued Without Obligations With Right To Sell And Issue
ValueOfCommonStockIssuedWithoutObligationsWithRightToSellAndIssue
100000000
CY2022Q2 kscp Threshold Period For For Execution Of Agreement
ThresholdPeriodForForExecutionOfAgreement
P24M
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27954933
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39347062
CY2022Q1 kscp Autonomous Security Robots Raw Materials
AutonomousSecurityRobotsRawMaterials
1369000
CY2021Q4 kscp Autonomous Security Robots Raw Materials
AutonomousSecurityRobotsRawMaterials
1041000
CY2022Q1 kscp Autonomous Security Robots In Progress
AutonomousSecurityRobotsInProgress
669000
CY2021Q4 kscp Autonomous Security Robots In Progress
AutonomousSecurityRobotsInProgress
427000
CY2022Q1 kscp Autonomous Security Robots Finished Product
AutonomousSecurityRobotsFinishedProduct
8183000
CY2021Q4 kscp Autonomous Security Robots Finished Product
AutonomousSecurityRobotsFinishedProduct
7695000
CY2022Q1 kscp Autonomous Security Robots Gross
AutonomousSecurityRobotsGross
10221000
CY2021Q4 kscp Autonomous Security Robots Gross
AutonomousSecurityRobotsGross
9163000
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make judgements, estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses. Specific accounts that require management estimates include, but are not limited to, estimating the useful lives of the Company’s ASRs and property and equipment, certain </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">estimates required within revenue recognition, estimating fair values of Company’s common stock, share-based awards and warrant liabilities, inclusive of any contingent assets and liabilities. Actual results could differ from those estimates and such differences may be material to the financial statements.</p>
CY2021Q4 kscp Autonomous Security Robots Accumulated Depreciation On Finished Product
AutonomousSecurityRobotsAccumulatedDepreciationOnFinishedProduct
6192000
CY2022Q1 kscp Autonomous Security Robots Net
AutonomousSecurityRobotsNet
3389000
CY2021Q4 kscp Autonomous Security Robots Net
AutonomousSecurityRobotsNet
2971000
CY2022Q1 kscp Autonomous Security Robots On Lease Or Available For Lease
AutonomousSecurityRobotsOnLeaseOrAvailableForLease
6968000
CY2021Q4 kscp Autonomous Security Robots On Lease Or Available For Lease
AutonomousSecurityRobotsOnLeaseOrAvailableForLease
6489000
CY2022Q1 kscp Demonstration Autonomous Security Robots
DemonstrationAutonomousSecurityRobots
585000
CY2021Q4 kscp Demonstration Autonomous Security Robots
DemonstrationAutonomousSecurityRobots
585000
CY2022Q1 kscp Research And Development Autonomous Security Robots
ResearchAndDevelopmentAutonomousSecurityRobots
320000
CY2021Q4 kscp Research And Development Autonomous Security Robots
ResearchAndDevelopmentAutonomousSecurityRobots
320000
CY2022Q1 kscp Autonomous Security Robots Docking Stations
AutonomousSecurityRobotsDockingStations
310000
CY2021Q4 kscp Autonomous Security Robots Docking Stations
AutonomousSecurityRobotsDockingStations
301000
CY2022Q1 kscp Autonomous Security Robots Finished Product
AutonomousSecurityRobotsFinishedProduct
8183000
CY2021Q4 kscp Autonomous Security Robots Finished Product
AutonomousSecurityRobotsFinishedProduct
7695000
CY2022Q1 kscp Autonomous Security Robots Accumulated Depreciation On Finished Product
AutonomousSecurityRobotsAccumulatedDepreciationOnFinishedProduct
6832000
CY2021Q4 kscp Autonomous Security Robots Accumulated Depreciation On Finished Product
AutonomousSecurityRobotsAccumulatedDepreciationOnFinishedProduct
6192000
CY2022Q1 kscp Autonomous Security Robots Finished Product Net
AutonomousSecurityRobotsFinishedProductNet
1351000
CY2021Q4 kscp Autonomous Security Robots Finished Product Net
AutonomousSecurityRobotsFinishedProductNet
1503000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
944000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
866000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1299000
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
357000
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
7109000
CY2021Q4 us-gaap Debt Current
DebtCurrent
7109000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
216003
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8799415
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.07
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y1M13D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
60924000
CY2022Q1 kscp Share Based Compensation Arrangement By Share Based Payment Award Options Shares Available For Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSharesAvailableForGrantsInPeriodGross
-100000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
100000
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.00
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
98001
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.99
CY2022Q1 kscp Share Based Compensation Arrangement By Share Based Payment Award Options Shares Available For Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSharesAvailableForForfeited
-307583
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
307583
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.68
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
423586
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8493831
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.12
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M13D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
58403000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3922831
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.20
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y9M29D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
34505000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.08
CY2022Q1 kscp Share Based Compensation Arrangement By Share Based Payment Award Shares Options Exercise
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesOptionsExercise
98001
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
284000
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
150000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
9225000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y8M1D
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1077000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
930000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
725000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
231000
CY2022Q1 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
43405324
CY2022Q1 kscp Temporary Equity Shares Issued And Outstanding
TemporaryEquitySharesIssuedAndOutstanding
13586502
CY2022Q1 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
39971000
CY2022Q1 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
42546000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8493831
CY2022Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5874600
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
423586
CY2022Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
28378519
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
672000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
648000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
307000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
485000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
979000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1133000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
193000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
764000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
563000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
507000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1070000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
91000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
979000
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y4M24D
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.120
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.120
CY2022Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
400000
CY2021Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
500000

Files In Submission

Name View Source Status
0001410578-22-001693-index-headers.html Edgar Link pending
0001410578-22-001693-index.html Edgar Link pending
0001410578-22-001693.txt Edgar Link pending
0001410578-22-001693-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20220331.xsd Edgar Link pending
tmb-20220331x10q.htm Edgar Link pending
tmb-20220331x10q_htm.xml Edgar Link completed
tmb-20220331xex31d1.htm Edgar Link pending
tmb-20220331xex31d2.htm Edgar Link pending
tmb-20220331xex32d1.htm Edgar Link pending
tmb-20220331xex32d2.htm Edgar Link pending
tmb-20220331_cal.xml Edgar Link unprocessable
tmb-20220331_def.xml Edgar Link unprocessable
tmb-20220331_lab.xml Edgar Link unprocessable
tmb-20220331_pre.xml Edgar Link unprocessable